Lindus Health has been shortlisted for the Fierce CRO Awards in the Outstanding Patient Recruitment and Retention Category
May 14, 2025
2
mins read
Lindus Health Named a 2025 Fierce CRO Award Finalist in the Outstanding Patient Recruitment and Retention Category
Lindusboards: Our Top 6 Immersive Therapeutics Companies
12/13/22
3
mins
Welcome to LindusBoards! We have spent some time looking at some of the most cutting-edge Digital Therapeutics companies, and we couldn't not share them with you. First up, some of the coolest immersive therapeutics companies in the space right now. Think healthcare meets virtual reality... and then some!
Product Clinic #7: It's a marathon, not a sprint
12/8/22
There is no better perspective of how our product team has grown and adapted as it has scaled than that of our first software engineer - Zaid! Our way of working is flexible and gives our engineers autonomy and the time to think meaningfully about what we need to build! Read our Product Clinic #7 to discover more about our engineering culture and how we balance speed and quality.
Discussing DTx challenges and go-to-market in the UK with Charlotte Lee-Sinclair (ex-Big Health)
11/17/22
A fireside chat, this time by an actual fire! Our conversation with Dr Charlotte Lee-Sinclair is a must-read on DTx challenges and the road to go-to-market in the UK. Read here.
Debunking the 3 biggest myths about decentralised trials
11/1/22
You've probably heard of decentralised clinical trials, but there are a lot of myths out there. Here we debunk the 3 biggest myths.
Product Clinic #6: Releasing, Fast and Slow
10/27/22
4
Depending on your background, our 6 to 8 week product release cycle will evoke one of two reactions. If you work in the clinical space: Woah, what an incredibly fast release cycle! But if you work in a typical SaaS startup: How quaint, I release 3 times a day! Heard of Daniel Kahnemann's bestseller Thinking, Fast and Slow? Well, there is our inspiration!
What taking intravenous ketamine taught me about clinical trial design
10/24/22
In the name of science, our co-founder, Meri Beckwith, took intravenous ketamine as part of a clinical trial. Find out what he has learnt about clinical trial design from his most recent trial experience.